3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
145
Stomach Neoplasms
22
Triple Negative Breast Neoplasms
21
Inflammatory Breast Neoplasms
14
Carcinoma, Hepatocellular
13
Esophageal Neoplasms
11
Lymphoma, Large B-Cell, Diffuse
7
Neoplasms
6
Pancreatic Neoplasms
5
Urinary Bladder Neoplasms
4
Adenocarcinoma Of Esophagus
4
Testicular Neoplasms
3
Sarcoma
3
Primary Breast Cancer
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Non-Muscle Invasive Bladder Neoplasms
3
Liver Neoplasms
3
Gallbladder Neoplasms
3
Carcinoma, Ductal, Breast
3
Breast Neoplasms, Male
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Recurrence
2
Pathologic Complete Response
2
Neoplastic Cells, Circulating
2
Neoplasms, Germ Cell and Embryonal
2
HER2-negative Breast Cancer
2
Carcinoma, Adenoid Cystic
2
Breast Diseases
2
pCR Rate
1
Women With Primary Breast Cancer
1
Interventions
Oxaliplatin
112
Fluorouracil
104
Leucovorin
91
Irinotecan
91
Capecitabine
59
Bevacizumab
58
Cetuximab
46
Folfox protocol
28
Colonoscopy
24
Panitumumab
19
Chemotherapy, Adjuvant
19
Blood Specimen Collection
19
Drug Therapy
18
Nivolumab
17
Magnetic Resonance Spectroscopy
17
Radiotherapy
16
Exercise
16
Early Intervention, Educational
16
Surveys and Questionnaires
15
Laparoscopy
15
Surgical Procedures, Operative
13
Floxuridine
13
Biopsy
13
trifluridine tipiracil drug combination
12
pembrolizumab
12
XELOX
12
Neoadjuvant Therapy
11
Methods
11
Immunohistochemistry
11
Celecoxib
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Colonic Neoplasms
×
Epirubicin
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled